Yahoo
NasdaqGM - Nasdaq Real Time Price USD

TScan Therapeutics, Inc. (TCRX)

0.1870 +0.0054 (+2.93%)
As of 1:31:02 PM EST. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Assets
228,789 371,118 272,149 199,091
Total Liabilities
105,666 130,148 121,282 99,657
Total Equity
123,123 240,970 150,867 99,434
Balance Sheet, Supplemental
Debt Maturity Schedule Total
32,534 32,072 30,047 29,290
Operating Lease Obligation Maturity Schedule Total
61,604 65,309 62,386 56,694
Total Debt
94,138 97,381 92,433 85,984
Net Debt
-58,268 -192,729 -99,611 -34,043
Working Capital
138,513 256,766 164,417 106,822
Invested Capital
217,261 338,351 243,300 185,418
Tangible Book Value
123,123 240,970 150,867 99,434
Common Equity Book Value
123,123 240,970 150,867 99,434
12/31/2022 - 7/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: